ResearcherFudan University Shanghai Cancer CenterNo recent work listed

Ye Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8052-9147; OpenAlex author ID A5068755596. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper

Papers 1

Nigericin Suppresses the Wnt/β-catenin Signaling in Pancreatic Cancer through Targeting pre-miR-374b-PRKCA/HBP1 Axis Last author DOI 10.21203/rs.3.rs-52126/v1 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei Li · 1 shared paper, 2020 · strength 0.11
- Paper Nigericin Suppresses the Wnt/β-catenin Signaling in Pancreatic Cancer through Targeting pre-miR-374b-PRKCA/HBP1 Axis DOI 10.21203/rs.3.rs-52126/v1 ↗
Dongming Zhu · 1 shared paper, 2020 · strength 0.11
- Paper Nigericin Suppresses the Wnt/β-catenin Signaling in Pancreatic Cancer through Targeting pre-miR-374b-PRKCA/HBP1 Axis DOI 10.21203/rs.3.rs-52126/v1 ↗
Min Jiang · 1 shared paper, 2020 · strength 0.11
- Paper Nigericin Suppresses the Wnt/β-catenin Signaling in Pancreatic Cancer through Targeting pre-miR-374b-PRKCA/HBP1 Axis DOI 10.21203/rs.3.rs-52126/v1 ↗
Zhihua Xu · 1 shared paper, 2020 · strength 0.11
- Paper Nigericin Suppresses the Wnt/β-catenin Signaling in Pancreatic Cancer through Targeting pre-miR-374b-PRKCA/HBP1 Axis DOI 10.21203/rs.3.rs-52126/v1 ↗
Qiaoming Zhi · 1 shared paper, 2020 · strength 0.11
- Paper Nigericin Suppresses the Wnt/β-catenin Signaling in Pancreatic Cancer through Targeting pre-miR-374b-PRKCA/HBP1 Axis DOI 10.21203/rs.3.rs-52126/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.